PCOS – Kinderwunsch und Schwangerschaft

Frauen mit der Diagnose PCOS haben ein höheres Risiko für Diabetes und eine gestörte Glukosetoleranz. Eine sorgfältige Beratung über Lebensstil, verbesserte Fruchtbarkeit und Schwangerschaft ist wichtig. Der Beitrag erläutert das Krankheitsbild und zeigt u. a. auf, in welchen Fällen Metformin zum Einsatz kommen kann, oder wann bei betroffenen Schwangeren auf die Entwicklung von Diabetes, Präeklampsie oder Hypertonie genauer zu achten ist.

Abstract

Polycystic ovary syndrome (PCOS) is diagnosed according to the Rotterdam criteria, where two of the following three criteria must be met: Anovulation, hyperandrogenism, and characteristic morphology by sonography. Women diagnosed with PCOS are at higher risk for diabetes and impaired glucose tolerance. Therefore, these women should be carefully counselled about lifestyle measures and improvements in fertility and pregnancy outcomes. Some women benefit from metformin, which needs to be clarified by off-label use. For fertility, mild stimulation is possible in women with unovulatory cycles, whereas women with PCOS need to be monitored more closely for the development of gestational diabetes, preeclampsia or hypertension during pregnancy.

Schlüsselwörter

PCOS - Kinderwunsch - Schwangerschaft - Metformin

Key words

PCOS - pregnancy - metformin - oligomenorrhea

• Literatur

• 1 Teede H, Misso M, Costello M. et al. International evidencebased guideline for the assessment and management of polycystic ovary syndrome. Melbourne (Australia): Monash University; 2018
• 2 Vink JM, Sadrzadeh S, Lambalk CB. et al. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab 2006; 91: 2100-2104
• 3 Chen ZJ, Zhao H, He L. et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 2011; 43: 55
• 4 Simonis-Bik AM, Nijpels G, van Haeften TW. et al. Gene variants in the novel type 2 diabetes loci CDC123 / CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function. Diabetes 2010; 59: 293-301
• 5 Mykhalchenko K, Lizneva D, Trofimova T. et al. Genetics of polycystic ovary syndrome. Expert Rev Mol Diagn 2017; 17: 723
• 6 Lerchbaum E, Trummer O, Giuliani A. et al. Susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21, and 9q33.3 in a cohort of Caucasian women. Horm Metab Res 2011; 43: 743
• 7 The Rotterdam ESHRE/ASRM‐sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-47
• 8 Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21: 1440-1447
• 9 Moran LJ, Misso ML, Wild RA. et al. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2010; 16: 347-363
• 10 Keck C. Adipositas – ein zunehmendes Problem. Frauenarzt 2018; 59: 9
• 11 Yang PK, Hsu CY, Chen MJ. et al. The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome. J Clin Endocrinol Metab 2018; 103: 890
• 12 Naderpoor N, Shorakae S, de Courten B. et al. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Hum Reprod Update 2015; 21: 560-574
• 13 Showell MG, Mackenzie-Proctor R, Jordan V. et al. Inositol for subfertile women with polycystic ovary syndrome. Cochr Data Syst Rev 2018; 12: CD012378
• 14 Cena H, Chiovato L, Nappi RE. Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists. J Clin Endocrinol Metab 2020; 105: e2695-e2709
• 15 Gemeinsamer Bundesausschuss (GBA). „Mutterschafts-Richtlinien“, zuletzt geändert am 16.09.2021, in Kraft getreten am 01.01.2022. Bundesanzeiger AT 26.11.21 B4.
• 16 Jorquera G, Echiburu’ B, Crisosto N. et al. Metformin during Pregnancy: Effects on Offspring Development and Metabolic Function. Front Pharmacol 2020; 11: 653
• 17 Løvvik TS, Carlsen SM, Salvesen Ø. et al. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 2019; 7: 256-266